These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10500079

  • 1. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion.
    Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ.
    Gastroenterology; 1999 Oct; 117(4):953-61. PubMed ID: 10500079
    [Abstract] [Full Text] [Related]

  • 2. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
    Yoshidome H, Lentsch AB, Cheadle WG, Miller FN, Edwards MJ.
    J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion.
    Yoshidome H, Kato A, Edwards MJ, Lentsch AB.
    Am J Physiol; 1999 Nov; 277(5):L919-23. PubMed ID: 10564176
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation.
    Lentsch AB, Jordan JA, Czermak BJ, Diehl KM, Younkin EM, Sarma V, Ward PA.
    Am J Pathol; 1999 Jan; 154(1):239-47. PubMed ID: 9916938
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells.
    Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ.
    Hepatology; 1998 Feb; 27(2):507-12. PubMed ID: 9462650
    [Abstract] [Full Text] [Related]

  • 7. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC.
    Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ.
    Hepatology; 1998 Apr; 27(4):1172-7. PubMed ID: 9537464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion.
    Kato A, Gabay C, Okaya T, Lentsch AB.
    Am J Pathol; 2002 Nov; 161(5):1797-803. PubMed ID: 12414526
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.
    Mulligan MS, Lentsch AB, Huber-Lang M, Guo RF, Sarma V, Wright CD, Ulich TR, Ward PA.
    Am J Pathol; 2000 Mar; 156(3):1033-9. PubMed ID: 10702419
    [Abstract] [Full Text] [Related]

  • 12. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC.
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [Abstract] [Full Text] [Related]

  • 13. IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion.
    Yoshidome H, Kato A, Miyazaki M, Edwards MJ, Lentsch AB.
    Am J Pathol; 1999 Oct; 155(4):1059-64. PubMed ID: 10514388
    [Abstract] [Full Text] [Related]

  • 14. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury.
    Kato A, Okaya T, Lentsch AB.
    Hepatology; 2003 Feb; 37(2):304-12. PubMed ID: 12540780
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells.
    Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, Burns JM, Tevar AD, Edwards MJ, Lentsch AB.
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1609-16. PubMed ID: 22646996
    [Abstract] [Full Text] [Related]

  • 18. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M.
    Hepatology; 2014 Apr; 59(4):1564-76. PubMed ID: 24282114
    [Abstract] [Full Text] [Related]

  • 19. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.
    Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU, Ding A.
    Crit Care Med; 2000 May; 28(5):1276-82. PubMed ID: 10834665
    [Abstract] [Full Text] [Related]

  • 20. Regulation of liver inflammatory injury by signal transducer and activator of transcription-6.
    Kato A, Yoshidome H, Edwards MJ, Lentsch AB.
    Am J Pathol; 2000 Jul; 157(1):297-302. PubMed ID: 10880399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.